Status:
ACTIVE_NOT_RECRUITING
Neuromodulation of Mind-Wandering in Depression
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Depression
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
The specific aim of this proposed study is to investigate the feasibility and therapeutic potential of LIFUP in changing negative cognition in depression. Specifically, the investigators will study if...
Detailed Description
The default mode network (DMN) is a network of structurally and functionally connected brain regions that was first identified during "passive" states. Since its initial discovery, the conceptualizati...
Eligibility Criteria
Inclusion
- Male or female
- Age 18-64
- Right-handed
- Normal or corrected-to normal vision and hearing
- For group with depression, current diagnosis of depression
Exclusion
- Active significant medical illness or neurological disorder
- MRI scan contraindications (e.g., metal implant, claustrophobia, weigh over 250 pounds, etc.)
- For healthy control group, any current or past history of psychiatric disorders
Key Trial Info
Start Date :
March 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04832685
Start Date
March 20 2023
End Date
April 1 2025
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114